<http://model.geneontology.org/382401246>
        a       <http://purl.obolibrary.org/obo/ECO_0000313> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-5637812" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-20" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:11087732" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://purl.obolibrary.org/obo/BFO_0000051>
        a       <http://www.w3.org/2002/07/owl#ObjectProperty> ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "has part" .

<http://purl.obolibrary.org/obo/RO_0002327>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "enables" .

<http://purl.org/pav/providedBy>
        a       <http://www.w3.org/2002/07/owl#AnnotationProperty> .

<http://purl.obolibrary.org/obo/RO_0002406>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "directly activates (process to process)" .

<http://purl.obolibrary.org/obo/BFO_0000002>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Continuant" .

<http://purl.obolibrary.org/obo/GO_0008150>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Biological Process" .

<http://purl.obolibrary.org/obo/RO_0002334>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "regulated by" .

<http://purl.obolibrary.org/obo/BFO_0000015>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Process" .

<http://purl.obolibrary.org/obo/RO_0002234>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "has output" .

<http://purl.obolibrary.org/obo/RO_0002413>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "directly provides input for (process to process)" .

<http://purl.obolibrary.org/obo/BFO_0000050>
        a       <http://www.w3.org/2002/07/owl#ObjectProperty> ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "part of" .

<http://purl.obolibrary.org/obo/GO_0032991>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Macromolecular Complex" ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/BFO_0000002> .

<http://purl.org/dc/elements/1.1/source>
        a       <http://www.w3.org/2002/07/owl#AnnotationProperty> .

<http://purl.obolibrary.org/obo/RO_0002333>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "enabled by" .

<http://purl.obolibrary.org/obo/RO_0002233>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "has input" .

<http://geneontology.org/lego/hint/layout/y>
        a       <http://www.w3.org/2002/07/owl#AnnotationProperty> .

<http://www.reactome.org/biopax/63/48887#Pathway1261>
        a       <http://www.biopax.org/release/biopax-level3.owl#Pathway> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "The pathway \"Signaling by EGFR in Cancer\" shows signaling by constitutively active EGFR cancer variants in the context of \"Signaling by EGFR\", allowing users to compare cancer events with the wild-type EGFR events. Red lines emphasize cancer related events and physical entities, while wild-type entities and events are shaded. Please refer to \"Signaling by Ligand-Responsive EGFR Variants in Cancer\", \"Signaling by EGFRvIII in Cancer\" and \"Signaling by Overexpressed Wild-Type EGFR in Cancer\" for detailed pathway summations." ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Signaling by EGFR in Cancer" ;
        <http://geneontology.org/lego/hint/layout/x>
                1800 ;
        <http://geneontology.org/lego/hint/layout/y>
                50 ;
        <http://purl.org/dc/elements/1.1/contributor>
                "Edited: Matthews, L, 2011-11-07" , "Edited: D'Eustachio, P, 2011-11-07" , "Reviewed: Greulich, H, 2011-11-15" , "Authored: Orlic-Milacic, M, 2011-11-04" , "https://reactome.org/content/detail/R-HSA-5637812" , "Edited: Haw, R, 2011-11-07" , "Edited: Gillespie, ME, 2011-11-07" , "Edited: Wu, G, 2011-11-07" , "Reviewed: Savas, S, 2011-11-15" , "Edited: Jassal, B, 2011-11-07" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-20" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

[ a       <http://www.w3.org/2002/07/owl#Axiom> ;
  <http://geneontology.org/lego/evidence>
          <http://model.geneontology.org/382401246> ;
  <http://purl.org/dc/elements/1.1/contributor>
          "https://reactome.org/content/detail/R-HSA-5637812" ;
  <http://purl.org/dc/elements/1.1/date>
          "2018-03-20" ;
  <http://purl.org/pav/providedBy>
          "https://reactome.org" ;
  <http://www.w3.org/2002/07/owl#annotatedProperty>
          <http://purl.obolibrary.org/obo/BFO_0000051> ;
  <http://www.w3.org/2002/07/owl#annotatedSource>
          <http://www.reactome.org/biopax/63/48887#Pathway1264> ;
  <http://www.w3.org/2002/07/owl#annotatedTarget>
          <http://www.reactome.org/biopax/63/48887#Pathway1265>
] .

<http://geneontology.org/lego/hint/layout/x>
        a       <http://www.w3.org/2002/07/owl#AnnotationProperty> .

<http://geneontology.org/lego/evidence>
        a       <http://www.w3.org/2002/07/owl#AnnotationProperty> .

<http://www.biopax.org/release/biopax-level3.owl#Pathway>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Pathway" ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/BFO_0000015> .

<http://purl.org/dc/elements/1.1/date>
        a       <http://www.w3.org/2002/07/owl#AnnotationProperty> .

<http://geneontology.org/lego/modelstate>
        a       <http://www.w3.org/2002/07/owl#AnnotationProperty> .

<http://purl.obolibrary.org/obo/RO_0001025>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "located in" .

<http://purl.obolibrary.org/obo/ECO_0000313>
        a       <http://www.w3.org/2002/07/owl#Class> .

<http://purl.obolibrary.org/obo/GO_0003674>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Molecular Function" .

<http://purl.obolibrary.org/obo/RO_0002429>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "involved in positive regulation_of" .

[ a       <http://www.w3.org/2002/07/owl#Axiom> ;
  <http://geneontology.org/lego/evidence>
          <http://model.geneontology.org/-192301861> ;
  <http://purl.org/dc/elements/1.1/contributor>
          "https://reactome.org/content/detail/R-HSA-5637812" ;
  <http://purl.org/dc/elements/1.1/date>
          "2018-03-20" ;
  <http://purl.org/pav/providedBy>
          "https://reactome.org" ;
  <http://www.w3.org/2002/07/owl#annotatedProperty>
          <http://purl.obolibrary.org/obo/BFO_0000050> ;
  <http://www.w3.org/2002/07/owl#annotatedSource>
          <http://www.reactome.org/biopax/63/48887#Pathway1264> ;
  <http://www.w3.org/2002/07/owl#annotatedTarget>
          <http://www.reactome.org/biopax/63/48887#Pathway1261>
] .

<http://purl.obolibrary.org/obo/RO_0002024>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "directly positively regulated by" .

<http://purl.obolibrary.org/obo/BFO_0000066>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "occurs in" .

<http://www.reactome.org/biopax/63/48887#Pathway1265>
        a       <http://www.w3.org/2002/07/owl#NamedIndividual> , <http://www.biopax.org/release/biopax-level3.owl#Pathway> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "In glioblastoma, the most prevalent EGFR mutation, present in ~25% of tumors, is the deletion of the ligand binding domain of EGFR, accompanied with amplification of the mutated allele, which results in over-expression of the mutant protein known as EGFRvIII. EGFRvIII mutant is not able to bind a ligand, but dimerizes and autophosphorylates spontaneously and is therefore constitutively active (Fernandes et al. 2001). Point mutations in the extracellular domain of EGFR are also frequently found in glioblastoma, but ligand binding ability and responsiveness are preserved (Lee et al. 2006). <br>Similar to EGFR kinase domain mutants, EGFRvIII mutant needs to maintain association with the chaperone heat shock protein 90 (HSP90) for proper functioning (Shimamura et al. 2005, Lavictoire et al. 2003). CDC37 is a co-chaperone of HSP90 that acts as a scaffold and regulator of interaction between HSP90 and its protein kinase clients. CDC37 is frequently over-expressed in cancers involving mutant kinases and acts as an oncogene (Roe et al. 2004, reviewed by Gray Jr. et al. 2008). <br>Expression of EGFRvIII mutant results in aberrant activation of downstream signaling cascades, namely RAS/RAF/MAP kinase signaling and PI3K/AKT signaling, and possibly signaling by PLCG1, which leads to increased cell proliferation and survival, providing selective advantage to cancer cells that harbor EGFRvIII (Huang et al. 2007). <br> EGFRvIII mutant does not autophosorylate on the tyrosine residue Y1045, a docking site for CBL, and is therefore unable to recruit CBL ubiquitin ligase, which enables it to escape degradation (Han et al. 2006)" ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Constitutive Signaling by EGFRvIII" ;
        <http://geneontology.org/lego/hint/layout/x>
                500 , 1150 ;
        <http://geneontology.org/lego/hint/layout/y>
                50 , 500 ;
        <http://purl.org/dc/elements/1.1/contributor>
                "Edited: Jassal, B, 2011-11-07" , "Edited: D'Eustachio, P, 2011-11-07" , "Authored: Orlic-Milacic, M, 2011-11-04" , "Reviewed: Savas, S, 2011-11-15" , "Reviewed: Greulich, H, 2011-11-15" , "Edited: Wu, G, 2011-11-07" , "Edited: Haw, R, 2011-11-07" , "Edited: Matthews, L, 2011-11-07" , "https://reactome.org/content/detail/R-HSA-5637812" , "Edited: Gillespie, ME, 2011-11-07" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-20" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://www.biopax.org/release/biopax-level3.owl#Reaction>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Reaction" ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/BFO_0000015> .

<http://purl.org/dc/elements/1.1/contributor>
        a       <http://www.w3.org/2002/07/owl#AnnotationProperty> .

<http://purl.obolibrary.org/obo/RO_0002408>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "directly inhibits (process to process)" .

<http://model.geneontology.org/1214470551>
        a       <http://www.w3.org/2002/07/owl#Ontology> ;
        <http://geneontology.org/lego/modelstate>
                "development" ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-5637812" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-20" ;
        <http://purl.org/dc/elements/1.1/title>
                "Reactome::Signaling by EGFRvIII in Cancer" .

<http://purl.obolibrary.org/obo/RO_0002430>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "involved in negative regulation_of" .

<http://www.biopax.org/release/biopax-level3.owl#Protein>
        a       <http://www.w3.org/2002/07/owl#Class> ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Protein" ;
        <http://www.w3.org/2000/01/rdf-schema#subClassOf>
                <http://purl.obolibrary.org/obo/BFO_0000002> .

<http://purl.org/dc/elements/1.1/title>
        a       <http://www.w3.org/2002/07/owl#AnnotationProperty> .

<http://purl.obolibrary.org/obo/RO_0002428>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "involved in regulation of" .

<http://purl.obolibrary.org/obo/RO_0002023>
        <http://www.w3.org/2000/01/rdf-schema#label>
                "directly negatively regulated by" .

<http://model.geneontology.org/-192301861>
        a       <http://purl.obolibrary.org/obo/ECO_0000313> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "https://reactome.org/content/detail/R-HSA-5637812" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-20" ;
        <http://purl.org/dc/elements/1.1/source>
                "PMID:11087732" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .

<http://www.reactome.org/biopax/63/48887#Pathway1264>
        a       <http://www.biopax.org/release/biopax-level3.owl#Pathway> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "EGFRvIII (EGFR V30_R297delinsG) is the most prevalent EGFR variant in glioblastoma, but it is also found in other cancer types. In-frame deletion of the ligand binding domain in EGFRvIII is frequently accompanied with genomic amplification, resulting in over-expression of EGFRvIII. EGFRvIII dimerizes and autophosphorylates spontaneously and is therefore constitutively active (Fernandes et al. 2001)" ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Signaling by EGFRvIII in Cancer" ;
        <http://geneontology.org/lego/hint/layout/x>
                500 ;
        <http://geneontology.org/lego/hint/layout/y>
                50 ;
        <http://purl.obolibrary.org/obo/BFO_0000050>
                <http://www.reactome.org/biopax/63/48887#Pathway1261> ;
        <http://purl.obolibrary.org/obo/BFO_0000051>
                <http://www.reactome.org/biopax/63/48887#Pathway1265> ;
        <http://purl.org/dc/elements/1.1/contributor>
                "Authored: Orlic-Milacic, M, 2011-11-04" , "Reviewed: Greulich, H, 2011-11-15" , "Edited: Wu, G, 2011-11-07" , "Edited: Gillespie, ME, 2011-11-07" , "Edited: Jassal, B, 2011-11-07" , "Reviewed: Savas, S, 2011-11-15" , "https://reactome.org/content/detail/R-HSA-5637812" , "Edited: Haw, R, 2011-11-07" , "Edited: Matthews, L, 2011-11-07" , "Edited: D'Eustachio, P, 2011-11-07" ;
        <http://purl.org/dc/elements/1.1/date>
                "2018-03-20" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" .
